Which one of the following is not true regarding the management of breast cancer?

Which one of the following is not true regarding the management of breast cancer?
A. Radiotherapy should be given in patients with node positive disease and after BCS
B. BCS and mastectomy are associated with same overall survival rate
C. Hormonal therapy is now given for 10 years
D. Molecular tests which help in determining whether chemotherapy is beneficial in early breast cancers, is only meant for patients who are ER, PR positive

D.

But i didnt know Hormonal therapy is now given for 10yrs

Correct answer is D.

Statement A is correct

Statement B is also correct. Overall survival is same but loco-regional recurrence is higher with BCS

Statement C - after the ATLAS trial, hormonal therapy is now given for 10 years

D is false. Molecular tests are useful to determine if chemotherapy can be avoided or not. Mammaprint considers Patients who are ER, PR positive and negative whereas oncotype Dx Only takes into account ER, PR positive patients.